Clinical Scorecard: Evaluation of the Effectiveness and Safety of Traditional Chinese Herbal Decoctions in the Treatment of Breast Cancer: A Network Meta-Analysis
At a Glance
Category
Detail
Condition
Breast Cancer
Key Mechanisms
Traditional Chinese herbal decoctions as adjunctive therapies to enhance treatment efficacy and alleviate side effects.
Target Population
Women diagnosed with breast cancer.
Care Setting
Oncology and integrative medicine.
Key Highlights
Network meta-analysis of 68 studies involving 4,708 patients.
YHHYT decoction showed the highest objective response rate.
BZT decoction ranked first for disease control rate and nausea relief.
FJHQT decoction improved immune function (CD4+/CD8+ ratio).
Traditional Chinese herbal decoctions can mitigate chemotherapy side effects.
Guideline-Based Recommendations
Diagnosis
Diagnosis of breast cancer should follow established clinical guidelines.
Management
Consider traditional Chinese herbal decoctions as adjunctive therapy in breast cancer treatment.
Monitoring & Follow-up
Monitor patient response to both conventional and adjunctive therapies.
Risks
Be aware of potential side effects and interactions with conventional treatments.
Patient & Prescribing Data
Women undergoing treatment for breast cancer.
Chinese herbal decoctions may improve quality of life and treatment outcomes.
Clinical Best Practices
Integrate traditional Chinese medicine with conventional oncology practices.
Individualize treatment plans based on patient needs and responses.
